Analyst Ratings for Candel Therapeutics Inc. (CADL)
CADL Rating Summary
CADL Price Target Summary
- Highest: $3.00 (BMO Capital)
- Lowest: $3.00 (BMO Capital)
- Average: $3.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$3.00 (-49.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2022 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
11.00 (N/A) |
1.80 (5.91) |
228.33% | Details |
| 11/19/2021 | BMO Capital » Updated 5/15/2023 |
Evan David Seigerman | New Coverage | Outperform (N/A) |
3.00 (9.00) |
10.60 (5.91) |
-44.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
